Overview

Early Albumin Resuscitation During Septic Shock

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Objective: To determine whether the early administration of albumin as an expander and antioxidant would improve survival on the 28th day for septic shock patients. Design: Prospective, multicenter, randomized, controlled versus saline, stratified on nosocomial infection and center. Setting: 27 Intensive Care Units (ICU) in France Coordinator: Pr J.P. Mira and Dr J. Charpentier - Cochin Hospital- Paris Patients: 800 patients could be included during the first 6 hours of their septic shock.
Phase:
Phase 4
Details
Lead Sponsor:
Laboratoire français de Fractionnement et de Biotechnologies